Abstract
This prospective, phase 2 study aimed at assessing the efficacy of accelerated fractionation radiation therapy by concomitant boosts (CBs) associated with chemoradiation therapy (CRT) of the whole pelvis, in improving the rate of pathological complete response (pCR) to treatment in patients with International Federation of Gynaecology and Obstetrics (FIGO) stage IB2-IVA locally advanced cervical cancer.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 778-785 |
| Numero di pagine | 8 |
| Rivista | International Journal of Radiation Oncology Biology Physics |
| Volume | 90 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2014 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
Keywords
- Adenocarcinoma
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Squamous Cell
- Chemoradiotherapy, Adjuvant
- Cisplatin
- Deoxycytidine
- Dose Fractionation
- Drug Administration Schedule
- Female
- Fluorouracil
- Humans
- Hysterectomy
- Lymph Node Excision
- Middle Aged
- Pelvis
- Prospective Studies
- Radiotherapy, Conformal
- Survival
- Uterine Cervical Neoplasms
Fingerprint
Entra nei temi di ricerca di 'Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver